| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity.
|
Science
|
2012
|
6.69
|
|
2
|
Functional improvement of dystrophic muscle by myostatin blockade.
|
Nature
|
2002
|
5.10
|
|
3
|
High-fat diet determines the composition of the murine gut microbiome independently of obesity.
|
Gastroenterology
|
2009
|
5.08
|
|
4
|
Regulation of fasted blood glucose by resistin.
|
Science
|
2004
|
3.54
|
|
5
|
Adiponectin acts in the brain to decrease body weight.
|
Nat Med
|
2004
|
3.47
|
|
6
|
Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology.
|
Nature
|
2008
|
3.23
|
|
7
|
Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1.
|
Nat Med
|
2012
|
2.86
|
|
8
|
Innate immunity modulates adipokines in humans.
|
J Clin Endocrinol Metab
|
2007
|
2.48
|
|
9
|
Foxa2 integrates the transcriptional response of the hepatocyte to fasting.
|
Cell Metab
|
2005
|
2.15
|
|
10
|
Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration.
|
Nat Med
|
2012
|
1.87
|
|
11
|
Antidiabetic effects of IGFBP2, a leptin-regulated gene.
|
Cell Metab
|
2010
|
1.85
|
|
12
|
Reduction of hepatosteatosis and lipid levels by an adipose differentiation-related protein antisense oligonucleotide.
|
Gastroenterology
|
2007
|
1.76
|
|
13
|
Inhibition of ADRP prevents diet-induced insulin resistance.
|
Am J Physiol Gastrointest Liver Physiol
|
2008
|
1.64
|
|
14
|
Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice.
|
J Clin Invest
|
2009
|
1.63
|
|
15
|
Role of endogenous glucagon-like peptide-1 in islet regeneration after partial pancreatectomy.
|
Diabetes
|
2003
|
1.55
|
|
16
|
TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome.
|
J Clin Endocrinol Metab
|
2010
|
1.48
|
|
17
|
Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling.
|
J Clin Invest
|
2011
|
1.46
|
|
18
|
Fractalkine is a novel human adipochemokine associated with type 2 diabetes.
|
Diabetes
|
2011
|
1.44
|
|
19
|
Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting.
|
Diabetes
|
2004
|
1.42
|
|
20
|
Loss of resistin improves glucose homeostasis in leptin deficiency.
|
Diabetes
|
2006
|
1.40
|
|
21
|
Central resistin induces hepatic insulin resistance via neuropeptide Y.
|
J Neurosci
|
2007
|
1.28
|
|
22
|
The 2011-2016 Transdisciplinary Research on Energetics and Cancer (TREC) initiative: rationale and design.
|
Cancer Causes Control
|
2013
|
1.26
|
|
23
|
Circadian rhythm profiles in women with night eating syndrome.
|
J Biol Rhythms
|
2009
|
1.19
|
|
24
|
Neuropeptide Y deficiency attenuates responses to fasting and high-fat diet in obesity-prone mice.
|
Diabetes
|
2006
|
1.19
|
|
25
|
Expression profiling reveals metabolic and structural components of extraocular muscles.
|
Physiol Genomics
|
2002
|
1.17
|
|
26
|
Effects of TNF-alpha neutralization on adipocytokines and skeletal muscle adiposity in the metabolic syndrome.
|
Am J Physiol Endocrinol Metab
|
2007
|
1.17
|
|
27
|
Neuroendocrine profiles associated with energy intake, sleep, and stress in the night eating syndrome.
|
J Clin Endocrinol Metab
|
2005
|
1.12
|
|
28
|
Mouse and human resistins impair glucose transport in primary mouse cardiomyocytes, and oligomerization is required for this biological action.
|
J Biol Chem
|
2005
|
1.09
|
|
29
|
Loss of resistin ameliorates hyperlipidemia and hepatic steatosis in leptin-deficient mice.
|
Am J Physiol Endocrinol Metab
|
2008
|
1.07
|
|
30
|
Adiponectin selectively inhibits oxytocin neurons of the paraventricular nucleus of the hypothalamus.
|
J Physiol
|
2007
|
1.06
|
|
31
|
Area postrema neurons are modulated by the adipocyte hormone adiponectin.
|
J Neurosci
|
2006
|
1.06
|
|
32
|
Loss of IL-15 receptor α alters the endurance, fatigability, and metabolic characteristics of mouse fast skeletal muscles.
|
J Clin Invest
|
2011
|
1.05
|
|
33
|
Reduction of TIP47 improves hepatic steatosis and glucose homeostasis in mice.
|
Am J Physiol Regul Integr Comp Physiol
|
2012
|
1.05
|
|
34
|
Akt deficiency attenuates muscle size and function but not the response to ActRIIB inhibition.
|
PLoS One
|
2010
|
1.02
|
|
35
|
Insulin secretion is increased in pancreatic islets of neuropeptide Y-deficient mice.
|
Endocrinology
|
2007
|
1.01
|
|
36
|
Targeting the activin type IIB receptor to improve muscle mass and function in the mdx mouse model of Duchenne muscular dystrophy.
|
Am J Pathol
|
2011
|
0.98
|
|
37
|
Estrogen sulfotransferase regulates body fat and glucose homeostasis in female mice.
|
Am J Physiol Endocrinol Metab
|
2010
|
0.97
|
|
38
|
Analysis of gene expression in pancreatic islets from diet-induced obese mice.
|
Physiol Genomics
|
2008
|
0.97
|
|
39
|
Low 24-hour adiponectin and high nocturnal leptin concentrations in a case-control study of community-dwelling premenopausal women with major depressive disorder: the Premenopausal, Osteopenia/Osteoporosis, Women, Alendronate, Depression (POWER) study.
|
J Clin Psychiatry
|
2010
|
0.96
|
|
40
|
Effects of perilipin 2 antisense oligonucleotide treatment on hepatic lipid metabolism and gene expression.
|
Physiol Genomics
|
2012
|
0.95
|
|
41
|
Maternal obesity associated with inflammation in their children.
|
World J Pediatr
|
2011
|
0.94
|
|
42
|
Divergent metabolic adaptations to intestinal parasitic nematode infection in mice susceptible or resistant to obesity.
|
Gastroenterology
|
2007
|
0.93
|
|
43
|
Ciliary neurotrophic factor and leptin induce distinct patterns of immediate early gene expression in the brain.
|
Diabetes
|
2004
|
0.93
|
|
44
|
A novel aminosterol reverses diabetes and fatty liver disease in obese mice.
|
J Hepatol
|
2004
|
0.91
|
|
45
|
Glomerular and tubular epithelial defects in kd/kd mice lead to progressive renal failure.
|
Am J Nephrol
|
2005
|
0.91
|
|
46
|
Inflammatory induction of human resistin causes insulin resistance in endotoxemic mice.
|
Diabetes
|
2011
|
0.90
|
|
47
|
Dominant inhibition of thyroid hormone action selectively in the pituitary of thyroid hormone receptor-beta null mice abolishes the regulation of thyrotropin by thyroid hormone.
|
Mol Endocrinol
|
2003
|
0.87
|
|
48
|
Overcoming insulin resistance with CNTF.
|
Nat Med
|
2006
|
0.86
|
|
49
|
Temporal effects of ethanol consumption on energy homeostasis, hepatic steatosis, and insulin sensitivity in mice.
|
Alcohol Clin Exp Res
|
2013
|
0.86
|
|
50
|
Metabolic dysfunction associated with adiponectin deficiency enhances kainic acid-induced seizure severity.
|
J Neurosci
|
2011
|
0.85
|
|
51
|
Convergence of IPMK and LKB1-AMPK signaling pathways on metformin action.
|
Mol Endocrinol
|
2014
|
0.83
|
|
52
|
Neuroendocrine and metabolic effects of adipocyte-derived hormones.
|
Clin Sci (Lond)
|
2006
|
0.83
|
|
53
|
Bariatric surgery: metabolic benefits beyond weight loss.
|
Gastroenterology
|
2011
|
0.81
|
|
54
|
Adipocytokine changes caused by low-carbohydrate compared to conventional diets in obesity.
|
Metab Syndr Relat Disord
|
2005
|
0.81
|
|
55
|
Obesity epidemic in need of answers.
|
Gastroenterology
|
2006
|
0.80
|
|
56
|
Systematic review of clinical studies related to pork intake and metabolic syndrome or its components.
|
Diabetes Metab Syndr Obes
|
2013
|
0.79
|
|
57
|
Gut peptides and other regulators in obesity.
|
Semin Liver Dis
|
2004
|
0.79
|
|
58
|
Insulin resistance: cause or consequence of nonalcoholic steatohepatitis?
|
Gastroenterology
|
2007
|
0.79
|
|
59
|
Alteration of hypothalamic cellular dynamics in obesity.
|
J Clin Invest
|
2011
|
0.79
|
|
60
|
The natural history of nonalcoholic fatty liver disease: insights from children and mice.
|
Gastroenterology
|
2008
|
0.77
|
|
61
|
Effect of isolated hyperglycemia on native mechanical and biologic shoulder joint properties in a rat model.
|
J Orthop Res
|
2014
|
0.76
|
|
62
|
Alas! Ileal interposition surgery for diabetes prevention?
|
Gastroenterology
|
2010
|
0.76
|
|
63
|
Should eligibility for bariatric surgery be expanded?
|
Gastroenterology
|
2008
|
0.76
|
|
64
|
Diabetes, Hemoglobin A1C, and Regional Alzheimer Disease and Infarct Pathology.
|
Alzheimer Dis Assoc Disord
|
2016
|
0.75
|
|
65
|
Boosting gut endocrinology with brain imaging.
|
Gastroenterology
|
2010
|
0.75
|
|
66
|
Intestinal lipids as signaling molecules.
|
Gastroenterology
|
2009
|
0.75
|